Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Avenue Therapeutics Inc
ATXICurrent price
1.85 USD
-0.07 USD (-3.65%)
Last closed
1.75 USD
Company
www.avenuetx.com
ISIN
US05360L3042
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 573 820 USD
Yield for 12 month
-82.63 %
1Y
3Y
5Y
10Y
15Y
ATXI
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc. Address: 1111 Kane Concourse, Bay Harbor Islands, FL, United States, 33154
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.00 USDP/E ratio
0.070Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures ATXI
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
0.070
Return On Assets TTM
-201.35 %
PEG Ratio
–
Return On Equity TTM
-535.10 %
Wall Street Target Price
8.00 USD
Revenue TTM
–
Book Value
4.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
24.78 USD
Diluted Eps TTM
24.78 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-76.30 %
Profit Margin
–
Dividend Analytics ATXI
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ATXI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:75
Payout Ratio
–
Last Split Date
26.04.2024
Dividend Date
–
Stock Valuation ATXI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.070
Forward PE
17.99
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.42
Price Book MRQ
1.37
Financials ATXI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATXI
For 52 weeks
1.60 USD
26.47 USD
50 Day MA
2.05 USD
Shares Short Prior Month
44 050
200 Day MA
4.51 USD
Short Ratio
0.73
Shares Short
46 762
Short Percent
3.56 %
BeatStart